BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 21590222)

  • 1. Proliferating cell nuclear antigen and argyrophilic nucleolar organizer regions in patients with thymic disease.
    Oyama T; Osaki T; Mitsudomi T; Mizoue T; Ohgami A; Nakanishi R; Sugio K; Yasumoto K
    Oncol Rep; 1997; 4(6):1201-5. PubMed ID: 21590222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
    Oyama T; Osaki T; Nose N; Ichiki Y; Inoue M; Imoto H; Yoshimatsu T; Kodate M; Uramoto H; Mizoue T; Yano K; Yasumoto K
    Anticancer Res; 2000; 20(1B):505-10. PubMed ID: 10769714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymic epithelial tumours: evaluation of malignant grade by quantification of proliferating cell nuclear antigen and nucleolar organizer regions.
    Tateyama H; Mizuno T; Tada T; Eimoto T; Hashimoto T; Masaoka A
    Virchows Arch A Pathol Anat Histopathol; 1993; 422(4):265-9. PubMed ID: 8099456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 alteration, proliferating cell nuclear antigen, and nucleolar organizer regions in thymic epithelial tumors.
    Oyama T; Osaki T; Mitsudomi T; Ogawa R; Nakanishi R; Sugio K; Yasumoto K
    Int J Mol Med; 1998 May; 1(5):823-6. PubMed ID: 9852302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleolar organizer regions and PCNA expression in prostatic cancers.
    Kawase N; Shiokawa A; Ota H; Saitoh T; Yoshida H; Kazama K
    Pathol Int; 1994 Mar; 44(3):213-22. PubMed ID: 7517763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical significance of proliferating cell nuclear antigen (PCNA) and argyrophilic nucleolar organizer region (AgNOR) in testicular tumors].
    Ohyama C; Ito A; Tokuyama S; Nakazumi H; Suzuki K; Kawamura S; Sato M; Saito S; Yoshikawa K; Hoshi S
    Nihon Hinyokika Gakkai Zasshi; 1995 Oct; 86(10):1543-51. PubMed ID: 7474604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The estimation of proliferative activity by pcna and AgNORs in leukoplakia and squamous-cell carcinoma of the oral cavity.
    Kanekawa A; Tsuji T; Mimura Y; Murakami T; Li X; Wen S; Shinozaki F
    Oncol Rep; 1995 Sep; 2(5):711-5. PubMed ID: 21597802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma.
    Vail DM; Kisseberth WC; Obradovich JE; Moore FM; London CA; MacEwen EG; Ritter MA
    Exp Hematol; 1996 Jun; 24(7):807-15. PubMed ID: 8647231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferating cell nuclear antigen may be superior to argyrophilic nucleolar organizer regions in predicting shortened survival of patients with non-small cell lung cancer.
    Oyama T; Mitsudomi T; Mizoue T; Ohgami A; Osaki T; Nakanishi R; Yasumoto K
    Surg Oncol; 1995; 4(2):83-9. PubMed ID: 7551263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of argyrophilic nucleolar organizer region and proliferating cell nuclear antigen in colorectal cancer.
    Nakae S; Nakamura T; Ikegawa R; Yoshioka H; Shirono J; Tabuchi Y
    J Surg Oncol; 1998 Sep; 69(1):28-35. PubMed ID: 9762888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proliferating cell nuclear antigen and nucleolar organizer regions in CNS tumors: correlation with histological type and tumor grade. A comparative study of 82 cases on paraffin sections.
    Korkolopoulou P; Christodoulou P; Papanikolaou A; Thomas-Tsagli E
    Am J Surg Pathol; 1993 Sep; 17(9):912-9. PubMed ID: 8102513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of proliferative potential of meningiomas using PCNA LI and AgNOR counts.
    Sudha K; Karak AK; Sharma MC; Mathur M; Sarkar C
    Indian J Pathol Microbiol; 1998 Jul; 41(3):323-30. PubMed ID: 9805855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of proliferating cell nuclear antigen and nucleolar organizer region in testicular tumors].
    Kurisu H; Shimabukuro T; Wada T; Yamamoto M; Shameem IA; Otsuka T; Sakano S; Matsuyama H; Naito K; Yamamoto N
    Hinyokika Kiyo; 1993 Aug; 39(8):715-20. PubMed ID: 8104387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleolar organizer regions (NORs) staining and proliferating cell nuclear antigen (PCNA) immunostaining in mucosa-associated lymphoid tissue (MALT) gastric lymphomas.
    Mikou P; Kanavaros P; Aninos D; Tzardi M; Karameris A; Gorgoulis B; Papadopoulos N; Lavergne A; Galian A
    Pathol Res Pract; 1993 Nov; 189(9):1004-9. PubMed ID: 7905623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Argyrophilic nucleolar organizer regions in colorectal malignancy: application of typing by their density.
    Iwashita T; Mori H; Ito Y; Obashi A; Sugimoto K; Tei H; Hirata I; Oshiba S
    Pathol Int; 1996 Mar; 46(3):204-10. PubMed ID: 10846571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative immunohistochemical studies of p53 and proliferating cell nuclear antigen expression and argyrophilic nucleolar organizer regions in pancreatic duct cell carcinomas.
    Suzuki T; Takano Y
    Jpn J Cancer Res; 1993 Oct; 84(10):1072-7. PubMed ID: 7901190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proliferating cell nuclear antigen and nucleolar organizer region for differential diagnosis of dysplasia and adenocarcinoma in gastric biopsies.
    Ozercan IH; Bahçecioglu IH; Ozercan MR; Bozlak N; Dogan C; Yekeler H
    Indian J Gastroenterol; 2000; 19(2):57-60. PubMed ID: 10812815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic significance of AgNOR counts and PCNA-positive cell counts in canine malignant lymphomas.
    Kiupel M; Bostock D; Bergmann V
    J Comp Pathol; 1998 Nov; 119(4):407-18. PubMed ID: 9839202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Argyrophilic nucleolar organizer region counts and proliferating cell nuclear antigen scores are two reliable indicators of survival in pharyngeal carcinoma.
    Pich A; Chiusa L; Pisani P; Krengli M; Pia F; Navone R
    J Cancer Res Clin Oncol; 1992; 119(2):106-10. PubMed ID: 1358893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of proliferative activity by AgNOR and PCNA in prostatic tissues of ram lambs implanted with zeranol.
    Gulbahar MY; Yuksel H; Guvenc T; Okut H
    Reprod Domest Anim; 2005 Oct; 40(5):468-74. PubMed ID: 16149954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.